Status:
UNKNOWN
Use of Bone Scintigraphy, CT and MRI in Breast Cancer
Lead Sponsor:
University of Aarhus
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-80 years
Brief Summary
A new imaging modality combining CT and tomographic bone scintigraphy (SPECT/CT) has enabled the combination of functional and anatomical imaging. Its use in cancer patients has not yet been evaluated...
Eligibility Criteria
Inclusion
- Histological verified breast cancer
- Age 18-80 years
- Investigation for metastases using imaging modality/modalities planned
- Written consent to participate in trial
Exclusion
- Overweight limiting the use of MRI
- Metal parts in body
- Claustrophobia
- Allergy to contrast agents used in trial
- Pregnancy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00682253
Start Date
May 1 2008
End Date
March 1 2011
Last Update
September 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8000